Complete Phase 1 trial and report full results for UNI-494
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Mar 2024
- Due
- 31 Dec 2024
- Delivered
- by 31 Dec 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We expect to complete the Phase 1 trial and report the full results in the second half of this year.”
What we found
Evidence strength A What the grades mean
The company successfully completed the Phase 1 trial of UNI-494 in 2024 and presented the results at the ASN 2024 conference, meeting the commitment to report results in the second half of 2024.
-
A Unicycive Therapeutics, Inc. 10-K filed 2025-03-31
“we have completed a Phase I clinical study in healthy volunteers with UNI-494 in 2024.” ✓ confirmed on the page
Market reaction: the shares moved -12.2% against the S&P 500 over the three sessions around the disclosure (28 Mar 2025 to 2 Apr 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- UNI-494 Phase 1 trial results
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Unicycive Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-UNCY-002796 · Corrections policy